LSD has gained a reputation for its use in counterculture, but recent developments show it could be used to treat anxiety. Mind Medicine Inc.'s LSD formulation, MM120, recently obtained breakthrough ...
LSD affects your brain by flooding it with serotonin — the neurotransmitter linked to mood and perception. This video explains why LSD can cause euphoria, hallucinations, and even anxiety, all from a ...
As it inches closer to FDA submissions for its psychedelic drug candidate, Definium Therapeutics is laying the groundwork for a future launch with an educational push about the pharmaceutical ...
NORTH CHARLESTON — One of the most notorious psychedelic drugs of the 1960s is showing promise as a treatment for psychiatric disorders and is being tested as therapy for anxiety in a Charleston-area ...
Two major trials investigating the potential of the psychedelic drug LSD for reducing anxiety are set to conclude in 2026. Scientists are feeling positive after the drug’s success in an earlier-stage ...
In 1943, biochemist Albert Hoffman accidentally ingested a chemical that he had synthesized from a fungus and discovered that it created hallucinations. The mind-bending chemical was lysergic acid ...
He helped make and distribute millions of LSD tablets in the 1970s. After seven years in prison, he ran mountain climbing expeditions in the Himalayas. By Richard Sandomir Henry Todd, a Scotsman who ...
University of Auckland researchers report that an 8-week, twice-weekly LSD microdosing regimen for major depressive disorder was feasible and well-tolerated, with Montgomery-Åsberg Depression Rating ...
A new study suggests that lysergic acid diethylamide (LSD), also known as acid, could reduce anxiety. This marks the first-ever trial to evaluate the safety and efficacy of MM120 (a pharmaceutical ...
One person’s acid trip could be another person’s anxiety therapy. That’s the tantalizing upshot from a new study that showed LSD may have the potential to alleviate anxiety. The findings are just the ...
LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned in the U.S. for ...